Our areas of research
Liryc is a research, treatment, innovation and teaching institute, wholly dedicated to the study, diagnosis and treatment of cardiac electrical disorders. These electrical disorders are responsible for various cardiovascular diseases and sudden deaths, and cause -directly or indirectly- around one third of all deaths in the world.
The strength of Liryc is the breadth and depth its scientific expertise, and its close association with internationally recognized clinical teams and information technology/modelling laboratories already based in Bordeaux.
Liryc constitutes a medical and scientific multidisciplinary program dedicated to the understanding of cardiac electrical dysfunctions. It addresses the most prevalent arrhythmia and main risk factors for embolic stroke: atrial fibrillation (the most lethal cardiac rhythm disorder), ventricular fibrillation and electrical ventricular dyssynchrony (leading to heart failure).
Atrial fibrillation, the most common arrhythmia, currently affects more than 10 million people in Europe, with a projection of 14-17 million by 2030. It is the most common cause of cardioembolic stroke and a risk factor for heart failure and dementia.
Ventricular fibrillation is responsible for 50,000 sudden cardiac deaths in France each year, too often likened to a natural death…. i.e. one sudden death every 10 minutes. The average age is 65 years old, half of the victims being younger subjects in employment.
Heart failure affects 9 million people in Europe, including 1 million in France; it constitutes 10% of all in-hospital admissions. It mainly affects persons of 65 years-old or more, but children and pregnant women can be also affected.